EuBiologics (206650.KQ) Earnings Analysis
EuBiologics (206650.KQ) has no confirmed upcoming earnings date. Trailing P/E 9.89.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 206650.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 206650.KQ. This page updates as the calendar is published.
206650.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 99.79 KRW | n/a | n/a | n/a |
| 2026-02-02 | 11.29 KRW | n/a | n/a | n/a |
| 2025-11-10 | 476 KRW | n/a | n/a | n/a |
| 2025-08-13 | 211 KRW | n/a | n/a | n/a |
| 2025-02-03 | 225.45 KRW | n/a | n/a | n/a |
| 2024-10-28 | 440.77 KRW | n/a | n/a | n/a |
206650.KQ valuation and analyst view
| Trailing P/E | 9.89 |
|---|---|
| Trailing EPS | 796.32 KRW |
| Price / book | 1.61 |
| Dividend yield | 0.00% |
| Market cap | 279.83B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is EuBiologics (206650.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 206650.KQ. This page updates as the calendar is published.
Did 206650.KQ beat earnings last quarter?
Consensus estimate data was not available for 206650.KQ's 2026-05-14 report.
What is 206650.KQ's current P/E ratio and EPS?
206650.KQ trades at a trailing P/E of 9.89 on trailing EPS of 796.3245063746323 KRW.
What do analysts rate 206650.KQ?
206650.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.